메뉴 건너뛰기




Volumn 14, Issue 1, 2014, Pages

"Fighting an uphill battle" : Experience with the HCV triple therapy: A qualitative thematic analysis

Author keywords

Hepatitis C; Protease inhibitor; Self management; Treatment experience

Indexed keywords

BOCEPREVIR; PROTEINASE INHIBITOR; TELAPREVIR; ANTIVIRUS AGENT; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; OLIGOPEPTIDE; PROLINE;

EID: 84907910754     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-507     Document Type: Article
Times cited : (10)

References (61)
  • 1
    • 80053339008 scopus 로고    scopus 로고
    • An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
    • 3229841, 21898493
    • Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011, 54:1433-1444. 10.1002/hep.24641, 3229841, 21898493.
    • (2011) Hepatology , vol.54 , pp. 1433-1444
    • Ghany, M.G.1    Nelson, D.R.2    Strader, D.B.3    Thomas, D.L.4    Seeff, L.B.5
  • 2
    • 84909629951 scopus 로고    scopus 로고
    • The Burden of liver disease in Europe. A review of available epidemiological data
    • Blachier M, Leleu H, Peck-Radosavljevic M, Valla D, Roudot-Thoraval F. The Burden of liver disease in Europe. A review of available epidemiological data. [http://www.easl.eu/assets/application/files/54ae845caec619f_file.pdf].
    • Blachier, M.1    Leleu, H.2    Peck-Radosavljevic, M.3    Valla, D.4    Roudot-Thoraval, F.5
  • 3
    • 59149085501 scopus 로고    scopus 로고
    • The global burden of hepatitis C
    • Lavanchy D. The global burden of hepatitis C. Liver Int 2009, 29(Suppl 1):74-81.
    • (2009) Liver Int , vol.29 , pp. 74-81
    • Lavanchy, D.1
  • 4
    • 84894354149 scopus 로고    scopus 로고
    • Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association
    • 3891474, 23714072
    • Hope VD, Eramova I, Capurro D, Donghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2014, 142:270-286. 10.1017/S0950268813000940, 3891474, 23714072.
    • (2014) Epidemiol Infect , vol.142 , pp. 270-286
    • Hope, V.D.1    Eramova, I.2    Capurro, D.3    Donghoe, M.C.4
  • 5
    • 34249341941 scopus 로고    scopus 로고
    • Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study
    • 1955506, 17344277
    • Neal KR. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 2007, 56:1098-1104. 10.1136/gut.2006.113217, 1955506, 17344277.
    • (2007) Gut , vol.56 , pp. 1098-1104
    • Neal, K.R.1
  • 6
    • 84857144025 scopus 로고    scopus 로고
    • The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
    • 22351712
    • Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007. Ann Intern Med 2012, 156:271. 10.7326/0003-4819-156-4-201202210-00004, 22351712.
    • (2012) Ann Intern Med , vol.156 , pp. 271
    • Ly, K.N.1    Xing, J.2    Klevens, R.M.3    Jiles, R.B.4    Ward, J.W.5    Holmberg, S.D.6
  • 7
    • 84858295907 scopus 로고    scopus 로고
    • Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations
    • Jacobson IM, Poordad F, Brown RS, Kwo PY, Reddy KR, Schiff E. Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations. J Viral Hepatitis 2012, 19:236-243.
    • (2012) J Viral Hepatitis , vol.19 , pp. 236-243
    • Jacobson, I.M.1    Poordad, F.2    Brown, R.S.3    Kwo, P.Y.4    Reddy, K.R.5    Schiff, E.6
  • 8
    • 84856410313 scopus 로고    scopus 로고
    • Antiviral strategies in hepatitis C virus infection
    • Sarrazin C, Hézode C, Zeuzem S, Pawlotsky J. Antiviral strategies in hepatitis C virus infection. J Hepatol 2012, 56:S88-S100.
    • (2012) J Hepatol , vol.56 , pp. S88-S100
    • Sarrazin, C.1    Hézode, C.2    Zeuzem, S.3    Pawlotsky, J.4
  • 9
    • 84872565980 scopus 로고    scopus 로고
    • Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review
    • 23437439
    • Chou R, Hartung D, Rahman B, Wasson N, Cottrell EB, Fu R. Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Ann Intern Med 2013, 158:114-123. 10.7326/0003-4819-158-2-201301150-00576, 23437439.
    • (2013) Ann Intern Med , vol.158 , pp. 114-123
    • Chou, R.1    Hartung, D.2    Rahman, B.3    Wasson, N.4    Cottrell, E.B.5    Fu, R.6
  • 10
    • 84873580144 scopus 로고    scopus 로고
    • Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials
    • 23369368
    • Sitole M, Silva M, Spooner L, Comee MK, Malloy M. Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials. Clin Ther 2013, 35:190-197. 10.1016/j.clinthera.2012.12.017, 23369368.
    • (2013) Clin Ther , vol.35 , pp. 190-197
    • Sitole, M.1    Silva, M.2    Spooner, L.3    Comee, M.K.4    Malloy, M.5
  • 11
    • 84858189451 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    • Moradpour D, Müllhaupt B, Swiss Association for the Study of the Liver [SASL] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. Swiss Med Wkly 2012, 142:w13516. Swiss Association for the Study of the Liver [SASL].
    • (2012) Swiss Med Wkly , vol.142 , pp. w13516
    • Moradpour, D.1    Müllhaupt, B.2
  • 12
    • 84855209804 scopus 로고    scopus 로고
    • Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow
    • Asselah T, Marcellin P. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow. Liver Int 2012, 32:88-102.
    • (2012) Liver Int , vol.32 , pp. 88-102
    • Asselah, T.1    Marcellin, P.2
  • 13
    • 84868596510 scopus 로고    scopus 로고
    • Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers
    • Bruggmann P. Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers. J Viral Hepatitis 2012, 19:829-8.
    • (2012) J Viral Hepatitis , vol.19 , pp. 829-838
    • Bruggmann, P.1
  • 14
    • 84903814910 scopus 로고    scopus 로고
    • Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study
    • Treloar C, Rance J, Dore GJ, Grebely J. Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study. J Viral Hepatitis 2014, 21:560-567.
    • (2014) J Viral Hepatitis , vol.21 , pp. 560-567
    • Treloar, C.1    Rance, J.2    Dore, G.J.3    Grebely, J.4
  • 15
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • 12324553
    • Fried MW, Shiffman ML, Reddy R, Smith C, Marinos Cea. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975-982. 10.1056/NEJMoa020047, 12324553.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, R.3    Smith, C.4    Cea, M.5
  • 16
    • 84871408060 scopus 로고    scopus 로고
    • Hepatitis C: Management of Side Effects in the Era of Direct-Acting Antivirals
    • Gaetano JN, Reau N. Hepatitis C: Management of Side Effects in the Era of Direct-Acting Antivirals. Curr Gastroenterol Rep 2013, 15(1):305.
    • (2013) Curr Gastroenterol Rep , vol.15 , Issue.1 , pp. 305
    • Gaetano, J.N.1    Reau, N.2
  • 17
    • 79952698204 scopus 로고    scopus 로고
    • Management of Hepatitis C Antiviral Therapy Adverse Effects
    • Sung H, Chang M, Saab S. Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepatol Rep 2011, 10:33-40.
    • (2011) Curr Hepatol Rep , vol.10 , pp. 33-40
    • Sung, H.1    Chang, M.2    Saab, S.3
  • 19
    • 0042090615 scopus 로고    scopus 로고
    • Self-management education: history, definition, outcomes, and mechanisms
    • Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Intern Med 2003, 26:1-7.
    • (2003) Ann Intern Med , vol.26 , pp. 1-7
    • Lorig, K.R.1    Holman, H.R.2
  • 20
    • 1542465181 scopus 로고    scopus 로고
    • The structure of everyday self-care decision making in chronic illness
    • 14658350
    • Thorne S, Paterson B, Russel C. The structure of everyday self-care decision making in chronic illness. Qual Health Res 2003, 13:1337-1352. 10.1177/1049732303258039, 14658350.
    • (2003) Qual Health Res , vol.13 , pp. 1337-1352
    • Thorne, S.1    Paterson, B.2    Russel, C.3
  • 21
    • 68149132783 scopus 로고    scopus 로고
    • Living with hepatitis C and treatment: the personal experiences of patients
    • 19583661
    • Sgorbini M, O'Brien L, Jackson D. Living with hepatitis C and treatment: the personal experiences of patients. J Clin Nurs 2009, 18:2282-2291. 10.1111/j.1365-2702.2009.02806.x, 19583661.
    • (2009) J Clin Nurs , vol.18 , pp. 2282-2291
    • Sgorbini, M.1    O'Brien, L.2    Jackson, D.3
  • 22
    • 84859339341 scopus 로고    scopus 로고
    • The tasks of self-managing hepatitis C: The significance of disclosure
    • 21736430
    • Fry M, Bates G. The tasks of self-managing hepatitis C: The significance of disclosure. Psychol Health 2012, 27:460-474. 10.1080/08870446.2011.592982, 21736430.
    • (2012) Psychol Health , vol.27 , pp. 460-474
    • Fry, M.1    Bates, G.2
  • 23
    • 84864379047 scopus 로고    scopus 로고
    • [Hepatitis C! Experience in diagnosis and medical treatment. A literature review]
    • 22661065
    • Künzler-Heule P, Panfil E. [Hepatitis C! Experience in diagnosis and medical treatment. A literature review]. Pflege 2012, 25:185-195. 10.1024/1012-5302/a000201, 22661065.
    • (2012) Pflege , vol.25 , pp. 185-195
    • Künzler-Heule, P.1    Panfil, E.2
  • 24
    • 84870486860 scopus 로고    scopus 로고
    • Adherence to Longterm Therapies: Evidence for Action
    • World Health Organization [WHO] Adherence to Longterm Therapies: Evidence for Action. [http://www.who.int/chp/knowledge/publications/adherence:report/en/], World Health Organization [WHO].
  • 25
    • 80052955087 scopus 로고    scopus 로고
    • Relationship between adherence to Hepatitis C Virus Therapy and virologic outcomes, Cohort Study
    • 3366635, 21930852
    • Lo Re V, Teal V, Localio AR, Amorosa VK, Kapalan DE. Relationship between adherence to Hepatitis C Virus Therapy and virologic outcomes, Cohort Study. Ann Intern Med 2011, 155(6):353-360. 10.7326/0003-4819-155-6-201109200-00003, 3366635, 21930852.
    • (2011) Ann Intern Med , vol.155 , Issue.6 , pp. 353-360
    • Lo Re, V.1    Teal, V.2    Localio, A.R.3    Amorosa, V.K.4    Kapalan, D.E.5
  • 26
    • 79952467802 scopus 로고    scopus 로고
    • Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study
    • 21382162
    • Marcellin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Varastet M, Lang J, Melin P, Cacoub P. Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int 2011, 31:516-524. 10.1111/j.1478-3231.2011.02461.x, 21382162.
    • (2011) Liver Int , vol.31 , pp. 516-524
    • Marcellin, P.1    Chousterman, M.2    Fontanges, T.3    Ouzan, D.4    Rotily, M.5    Varastet, M.6    Lang, J.7    Melin, P.8    Cacoub, P.9
  • 28
    • 84864206329 scopus 로고    scopus 로고
    • Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C
    • 22812557
    • Gao X, Stephens JM, Carter JA, Haider S, Rustgi VK. Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. Expert Rev Pharmacoecon Outcomes Res 2012, 12:335-343. 10.1586/erp.12.10, 22812557.
    • (2012) Expert Rev Pharmacoecon Outcomes Res , vol.12 , pp. 335-343
    • Gao, X.1    Stephens, J.M.2    Carter, J.A.3    Haider, S.4    Rustgi, V.K.5
  • 29
    • 84855935309 scopus 로고    scopus 로고
    • The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice
    • 21718669
    • Weiss JJ, Alcorn MC, Rabkin JG, Dieterich DT. The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice. J Hepatol 2012, 56:503-504. 10.1016/j.jhep.2011.05.014, 21718669.
    • (2012) J Hepatol , vol.56 , pp. 503-504
    • Weiss, J.J.1    Alcorn, M.C.2    Rabkin, J.G.3    Dieterich, D.T.4
  • 31
    • 84887544404 scopus 로고    scopus 로고
    • The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year
    • 23445604
    • Groessl EJ, Ho SB, Asch SM, Stepnowsky CJ, Laurent D, Gifford AL. The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year. Health Educ Behav 2013, 40:730-740. 10.1177/1090198113477112, 23445604.
    • (2013) Health Educ Behav , vol.40 , pp. 730-740
    • Groessl, E.J.1    Ho, S.B.2    Asch, S.M.3    Stepnowsky, C.J.4    Laurent, D.5    Gifford, A.L.6
  • 32
    • 84879806759 scopus 로고    scopus 로고
    • Increasing antiviral treatment through integrated hepatitis C care: A randomized multicenter trial
    • Groessl EJ, Sklar M, Cheung RC, Bräu N, Ho SB. Increasing antiviral treatment through integrated hepatitis C care: A randomized multicenter trial. Contemp Clin Trials 2013, 35:97-107.
    • (2013) Contemp Clin Trials , vol.35 , pp. 97-107
    • Groessl, E.J.1    Sklar, M.2    Cheung, R.C.3    Bräu, N.4    Ho, S.B.5
  • 33
    • 84907917209 scopus 로고    scopus 로고
    • Executive Summary of ASMP/CDSMP Meta Analysis
    • Brady TJ, Murphy L. Executive Summary of ASMP/CDSMP Meta Analysis. [http://www.cdc.gov/arthritis/docs/ASMP-executive-summary.pdf].
    • Brady, T.J.1    Murphy, L.2
  • 34
    • 84861117640 scopus 로고    scopus 로고
    • Helping the people help themselves. A review of the evidence considering whether it is worthwhile to support self-management
    • DeSilva D. Helping the people help themselves. A review of the evidence considering whether it is worthwhile to support self-management. [http://www.health.org.uk/public/cms/75/76/313/2434/Helping%20people%20help%20themselves.pdf?realName=8mh12J.pdf].
    • DeSilva, D.1
  • 35
    • 84873403998 scopus 로고    scopus 로고
    • Adherence and Completion in Hepatitis C Management
    • 23364367
    • Redulla R, Dudley-Brown S. Adherence and Completion in Hepatitis C Management. Gastroenterol Nurs 2013, 36:53-58. 10.1097/SGA.0b013e318281634e, 23364367.
    • (2013) Gastroenterol Nurs , vol.36 , pp. 53-58
    • Redulla, R.1    Dudley-Brown, S.2
  • 36
    • 84904707593 scopus 로고    scopus 로고
    • EASL Recommendations on Treatment of Hepatitis C 2014
    • European Assosciation for the study of the liver EASL Recommendations on Treatment of Hepatitis C 2014. J Hepatol 2014, 61:373-395. European Assosciation for the study of the liver.
    • (2014) J Hepatol , vol.61 , pp. 373-395
  • 38
    • 33750505977 scopus 로고    scopus 로고
    • Using thematic analysis in psychology
    • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006, 3:77-101.
    • (2006) Qual Res Psychol , vol.3 , pp. 77-101
    • Braun, V.1    Clarke, V.2
  • 40
    • 79953123168 scopus 로고    scopus 로고
    • Toward Methodological Emancipation in Applied Health Research
    • 21164035
    • Thorne S. Toward Methodological Emancipation in Applied Health Research. Qual Health Res 2011, 21:443-453. 10.1177/1049732310392595, 21164035.
    • (2011) Qual Health Res , vol.21 , pp. 443-453
    • Thorne, S.1
  • 41
    • 0030453840 scopus 로고    scopus 로고
    • Sampling for qualitative research
    • Marshall MN. Sampling for qualitative research. J Fam Practice 1996, 13:522-525.
    • (1996) J Fam Practice , vol.13 , pp. 522-525
    • Marshall, M.N.1
  • 43
    • 84867714206 scopus 로고    scopus 로고
    • Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection
    • 3333810, 22536063
    • Clark B, Garcia-Tsao F. Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection. Patient Prefer Adherence 2012, 6:285-295. 3333810, 22536063.
    • (2012) Patient Prefer Adherence , vol.6 , pp. 285-295
    • Clark, B.1    Garcia-Tsao, F.2
  • 44
    • 84878008414 scopus 로고    scopus 로고
    • Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
    • Fusfeld L, Aggarwal J, Dougher C, Vera-Llonch M, Bubb Sea. Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection. BMC Infec Dis 2013, 13:234.
    • (2013) BMC Infec Dis , vol.13 , pp. 234
    • Fusfeld, L.1    Aggarwal, J.2    Dougher, C.3    Vera-Llonch, M.4    Sea, B.5
  • 45
    • 84859067322 scopus 로고    scopus 로고
    • New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials
    • 22420497
    • Lee LY, Tong CY, Wong T, Wilkinson M. New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials. Int J Clin Pract 2012, 66:342-355. 10.1111/j.1742-1241.2012.02895.x, 22420497.
    • (2012) Int J Clin Pract , vol.66 , pp. 342-355
    • Lee, L.Y.1    Tong, C.Y.2    Wong, T.3    Wilkinson, M.4
  • 46
    • 57649096278 scopus 로고    scopus 로고
    • 'If it almost kills you that means it's working!' Cultural models of chemotherapy expressed in a cancer support group
    • 19010578
    • Bell K. 'If it almost kills you that means it's working!' Cultural models of chemotherapy expressed in a cancer support group. Soc Sci Med 2009, 68:169-176. 10.1016/j.socscimed.2008.10.023, 19010578.
    • (2009) Soc Sci Med , vol.68 , pp. 169-176
    • Bell, K.1
  • 47
    • 84872039392 scopus 로고    scopus 로고
    • How to optimize HCV therapy in genotype 1 patients: management of side-effects
    • Chopra A, Klein PL, Drinnan T, Lee SS. How to optimize HCV therapy in genotype 1 patients: management of side-effects. Liver Int 2013, 33:30-34.
    • (2013) Liver Int , vol.33 , pp. 30-34
    • Chopra, A.1    Klein, P.L.2    Drinnan, T.3    Lee, S.S.4
  • 49
    • 84871311662 scopus 로고    scopus 로고
    • Perceived HIV symptom manageability: synthesis of a new use for a known concept
    • 22765386
    • Fierz K, Nicca D, Spirig R. Perceived HIV symptom manageability: synthesis of a new use for a known concept. J Adv Nurs 2013, 69:229-241. 10.1111/j.1365-2648.2012.06068.x, 22765386.
    • (2013) J Adv Nurs , vol.69 , pp. 229-241
    • Fierz, K.1    Nicca, D.2    Spirig, R.3
  • 52
    • 84881330219 scopus 로고    scopus 로고
    • Relationship between HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework
    • 3738573, 23950897
    • Audet CM, McGowan CC, Wallston KA, Kipp Aaron M. Relationship between HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. PLoS ONE 2013, 8:e69564. 10.1371/journal.pone.0069564, 3738573, 23950897.
    • (2013) PLoS ONE , vol.8 , pp. e69564
    • Audet, C.M.1    McGowan, C.C.2    Wallston, K.A.3    Kipp Aaron, M.4
  • 53
    • 84878560450 scopus 로고    scopus 로고
    • HIV Stigma Mechanisms and Well-Being Among PLWH: A Test of the HIV Stigma Framework
    • 3664141, 23456594
    • Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV Stigma Mechanisms and Well-Being Among PLWH: A Test of the HIV Stigma Framework. AIDS Behav 2013, 17:1785-1795. 10.1007/s10461-013-0437-9, 3664141, 23456594.
    • (2013) AIDS Behav , vol.17 , pp. 1785-1795
    • Earnshaw, V.A.1    Smith, L.R.2    Chaudoir, S.R.3    Amico, K.R.4    Copenhaver, M.M.5
  • 55
    • 84867671977 scopus 로고    scopus 로고
    • Empirical Studies of Self-Stigma Reduction Strategies: A Critical Review of the Literature
    • Mittal D, Sullivan G, Chekuri L, Allee E, Corrigan PW. Empirical Studies of Self-Stigma Reduction Strategies: A Critical Review of the Literature. Psych Serv 2012, 63:974-981.
    • (2012) Psych Serv , vol.63 , pp. 974-981
    • Mittal, D.1    Sullivan, G.2    Chekuri, L.3    Allee, E.4    Corrigan, P.W.5
  • 56
    • 84860243899 scopus 로고    scopus 로고
    • Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives
    • 22154094
    • Stewart BJ, Mikocka-Walus AA, Harley H, Andrews JM. Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives. INT J NURS STUD 2012, 49:560-569. 10.1016/j.ijnurstu.2011.11.004, 22154094.
    • (2012) INT J NURS STUD , vol.49 , pp. 560-569
    • Stewart, B.J.1    Mikocka-Walus, A.A.2    Harley, H.3    Andrews, J.M.4
  • 57
    • 9144274620 scopus 로고    scopus 로고
    • Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
    • 313896, 14703538
    • Young J, Geest de S, Spiring R, Plepp M, Rickenbach Mea. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ 2004, 328:15. 10.1136/bmj.328.7430.15, 313896, 14703538.
    • (2004) BMJ , vol.328 , pp. 15
    • Young, J.1    Geest de, S.2    Spiring, R.3    Plepp, M.4    Mea, R.5
  • 58
    • 77956938619 scopus 로고    scopus 로고
    • Patients' perceptions of information and support received from the nurse specialist during HCV treatment
    • 20846231
    • Grogan A, Timmins F. Patients' perceptions of information and support received from the nurse specialist during HCV treatment. J CLIN NURS 2010, 19:2869-2878. 10.1111/j.1365-2702.2010.03239.x, 20846231.
    • (2010) J CLIN NURS , vol.19 , pp. 2869-2878
    • Grogan, A.1    Timmins, F.2
  • 61
    • 84928590389 scopus 로고    scopus 로고
    • Adherence During Antiviral Treatment Regimens for Chronic Hepatitis C: A Qualitative Study of Patient-reported Facilitators and Barriers
    • [Epub ahead of print]
    • Evon DM, Golin CE, Bonner JE, Grodensky C, Velloza J. Adherence During Antiviral Treatment Regimens for Chronic Hepatitis C: A Qualitative Study of Patient-reported Facilitators and Barriers. J Clin Gastroenterol 2014, [Epub ahead of print].
    • (2014) J Clin Gastroenterol
    • Evon, D.M.1    Golin, C.E.2    Bonner, J.E.3    Grodensky, C.4    Velloza, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.